|
LOC339290 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.583700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.083270E-03 |
| Normal-vs-Stage2 |
5.021700E-02 |
| Normal-vs-Stage3 |
6.830600E-04 |
| Normal-vs-Stage4 |
9.103400E-03 |
| Stage1-vs-Stage2 |
9.049800E-01 |
| Stage1-vs-Stage3 |
1.640200E-01 |
| Stage1-vs-Stage4 |
2.055200E-01 |
| Stage2-vs-Stage3 |
2.102600E-01 |
| Stage2-vs-Stage4 |
1.575430E-01 |
| Stage3-vs-Stage4 |
7.180200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.201200E-04 |
| Normal-vs-AfricanAmerican |
1.367950E-02 |
| Normal-vs-Asian |
3.65369999999476E-06 |
| Caucasian-vs-AfricanAmerican |
5.901400E-01 |
| Caucasian-vs-Asian |
4.998900E-03 |
| AfricanAmerican-vs-Asian |
3.133600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.302080E-03 |
| Normal-vs-Female |
4.000000E-04 |
| Male-vs-Female |
2.638800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.365560E-02 |
| Normal-vs-Extreme_Weight |
2.881400E-03 |
| Normal-vs-Obese |
4.935000E-03 |
| Normal-vs-Extreme_Obese |
6.436400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.067800E-01 |
| Normal_Weight-vs-Obese |
8.929400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.412600E-01 |
| Extreme_Weight-vs-Obese |
7.796200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.436200E-01 |
| Obese-vs-Extreme_Obese |
3.250400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.004160E-02 |
| Normal-vs-Age(41-60Yrs) |
7.873800E-02 |
| Normal-vs-Age(61-80Yrs) |
2.64390000004333E-06 |
| Normal-vs-Age(81-100Yrs) |
2.798000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.489200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.896000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.454400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.440300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.452200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.288000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.995600E-02 |
| Normal-VS-Type2 PRCC |
1.71810000004768E-06 |
| Normal-VS-KIRP CIMP |
4.03290000000611E-05 |
| Normal-VS-Unclassified PRCC |
2.935500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.765000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.327800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.275900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.538800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.360800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.560400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.515300000001E-05 |
| Normal-vs-N1 |
1.027780E-02 |
| Normal-vs-N2 |
2.435700E-03 |
| N0-vs-N1 |
7.130200E-01 |
| N0-vs-N2 |
6.318600E-01 |
| N1-vs-N2 |
5.594800E-01 |
|
|
